Selective Laser Trabeculoplasty (SLT) is an advanced laser system that targets specific cells of the eye — those containing melanin, a natural pigment. Using a special wavelength and energy, the SLT targets these specific cells in the trabecular meshwork (outflow barrier inside your eye), leaving the surrounding tissue intact, and improves the flow of fluid in the eye, thereby lowering your eye pressure. Your eye pressure may drop as quickly as a day or more after having the SLT procedure. You may be treated with anti-inflammatory eye drops that will be continued after the procedure. There are no incidences of allergy or systemic side effects with SLT. The SLT treatment does not cause pain. The SLT procedure is reimbursed by Medicare and many other insurance providers, which minimizes your out-of-pocket expenses.
- Safe: SLT is not associated with systemic side effects or the compliance and cost issues of medications.
- Selective: SLT utilizes selective photothermolysis to target only specific cells, leaving the surrounding tissue intact.
- Smart: SLT stimulates the body’s natural mechanisms to enhance outflow of the fluid in your eye.
- Sensible: SLT therapy is reimbursed by Medicare and many other insurance providers, which minimizes your out-of-pocket expenses.